1. Home
  2. VALN vs NOAH Comparison

VALN vs NOAH Comparison

Compare VALN & NOAH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VALN
  • NOAH
  • Stock Information
  • Founded
  • VALN 2012
  • NOAH 2005
  • Country
  • VALN France
  • NOAH China
  • Employees
  • VALN N/A
  • NOAH N/A
  • Industry
  • VALN Biotechnology: Biological Products (No Diagnostic Substances)
  • NOAH Investment Managers
  • Sector
  • VALN Health Care
  • NOAH Finance
  • Exchange
  • VALN Nasdaq
  • NOAH Nasdaq
  • Market Cap
  • VALN 777.9M
  • NOAH 767.0M
  • IPO Year
  • VALN 2021
  • NOAH 2010
  • Fundamental
  • Price
  • VALN $10.44
  • NOAH $11.61
  • Analyst Decision
  • VALN Strong Buy
  • NOAH Buy
  • Analyst Count
  • VALN 4
  • NOAH 2
  • Target Price
  • VALN $15.75
  • NOAH $12.25
  • AVG Volume (30 Days)
  • VALN 77.5K
  • NOAH 209.1K
  • Earning Date
  • VALN 11-06-2025
  • NOAH 11-25-2025
  • Dividend Yield
  • VALN N/A
  • NOAH 5.07%
  • EPS Growth
  • VALN N/A
  • NOAH N/A
  • EPS
  • VALN N/A
  • NOAH 0.75
  • Revenue
  • VALN $230,566,060.00
  • NOAH $360,100,505.00
  • Revenue This Year
  • VALN $15.69
  • NOAH N/A
  • Revenue Next Year
  • VALN $22.15
  • NOAH $5.17
  • P/E Ratio
  • VALN N/A
  • NOAH $15.35
  • Revenue Growth
  • VALN 25.47
  • NOAH N/A
  • 52 Week Low
  • VALN $3.62
  • NOAH $7.67
  • 52 Week High
  • VALN $12.25
  • NOAH $13.84
  • Technical
  • Relative Strength Index (RSI)
  • VALN 51.09
  • NOAH 47.97
  • Support Level
  • VALN $10.08
  • NOAH $10.92
  • Resistance Level
  • VALN $11.35
  • NOAH $12.07
  • Average True Range (ATR)
  • VALN 0.43
  • NOAH 0.43
  • MACD
  • VALN -0.13
  • NOAH -0.02
  • Stochastic Oscillator
  • VALN 29.25
  • NOAH 44.70

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

About NOAH Noah Holdings Limited

Noah Holdings Ltd is a wealth management service provider offering comprehensive advisory services on investment and asset allocation, mainly for Mandarin-speaking high-net-worth (HNW) investors. The company's operating segments are Domestic public securities, Domestic asset management, Domestic insurance, Overseas wealth management, Overseas asset management, Overseas insurance and comprehensive services, and Headquarters. Maximum revenue is generated from its Domestic asset management business, which manages private equity funds, real estate equity funds, and private secondary products. The domestic asset management operations focus on managing primary market exits and cross-border ETF products in the secondary market. Geographically, it derives maximum revenue from Mainland China.

Share on Social Networks: